Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

"FFM ME-TRAP" is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara) delivering the pre-erythrocytic malaria antigen ME-TRAP. Over nine months follow-up in our original study, there was no evidence that FFM ME-TRAP provided protection again...

Full description

Bibliographic Details
Main Authors: Philip Bejon, Edna Ogada, Tabitha Mwangi, Paul Milligan, Trudie Lang, Greg Fegan, Sarah C Gilbert, Norbert Peshu, Kevin Marsh, Adrian V S Hill
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-08-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC1940326?pdf=render